Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion
NCT ID: NCT03692845
Last Updated: 2018-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2018-11-30
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion
NCT04778943
Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases
NCT06545032
Midline Lumbar Fusion Versus Posterior Lumbar Interbody Fusion
NCT02290314
MIS MiLIF Versus Open
NCT00792129
Evaluation of Treatment Effect of Minimally Invasive Spinal Fusion Surgery
NCT05190055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
O-TLIF group
Spinal fusion ,Transforaminal lumbar interbody fusion procedure will be performed through open surgery.
Transforaminal Lumbar Interbody Fusion either open or minimally invasive
Spinal fusion procedure through the intervertebral foramen
MI-TLIF group
Spinal fusion,Transforaminal lumbar interbody fusion procedure will be performed through minimally invasive surgery using a tubular retractor.
Transforaminal Lumbar Interbody Fusion either open or minimally invasive
Spinal fusion procedure through the intervertebral foramen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transforaminal Lumbar Interbody Fusion either open or minimally invasive
Spinal fusion procedure through the intervertebral foramen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Degenerative or isthmic spondylolithesis Grade 1,2 and 3.
* Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural compression.
* Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1.
* Symptoms not responding to conservative treatment for at least 3 months.
Exclusion Criteria
* Spinal tumours, infection and fractures.
* Patients with severe osteoporosis
* BMI more than 35.
* Non-ambulant patients and patients with severe preoperative neurological affection (Cauda Equina Syndrome)
* Patients not willing to participate in the study
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr Hatem Ahmed Mohammed
Assistant lecturer
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6272829
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.